IBS Relief: Gut Health and Microbiome Insights

Electroacupuncture was applied in half of all recent experimental studies investigating acupuncture for irritable bowel syndrome. This finding comes from a 2026 systematic analysis that reviewed five years of preclinical research to identify trends and gaps in understanding how acupuncture and moxibustion work for IBS.

**Five Years of Research Reveals Six Key Action Pathways**

A team from the Shanghai University of TCM and Shanghai Research Institute of Acupuncture and Meridian screened 124 relevant experimental studies published between 2020 and 2024. Their analysis, published in *Zhongguo Zhen Jiu*, identified six primary biological pathways through which acupuncture appears to exert its effects. The research is heavily concentrated on the regulation of visceral hypersensitivity, addressed in 81% of the studies. The other major pathways include the modulation of inflammatory factors, direct regulation of the intestinal microbiota, protection of the gut barrier function, improvement of behavioral and depressive symptoms, and correction of metabolic disturbances.

This multi-pathway view aligns with the complex, biopsychosocial nature of IBS, suggesting acupuncture may offer a systemic rather than a single-target intervention. For instance, by simultaneously influencing gut motility, local immunity, and the microbial environment, it targets several interconnected aspects of the condition.

**Electroacupuncture and Three Core Acupoints Dominate IBS-D Studies**

The review provides a clear snapshot of current experimental practice. Of the 124 studies, 66 (53%) specifically focused on diarrhea-predominant IBS (IBS-D). In these IBS-D studies, the most common methods for creating animal models were chronic acute combined stress and restraint stress combined with senna gavage.

Electroacupuncture, where a gentle electrical current is passed between acupuncture needles, was the most frequently employed technique, appearing in 50% of the treatment protocols. The acupoints selected were highly consistent. Zusanli (ST36) was used 78 times, Tianshu (ST25) 76 times, and Shangjuxu (ST37) 52 times. Together, these three points accounted for nearly 70% of all acupoint applications in the reviewed research. Their selection is rooted in traditional Chinese medicine principles for treating gastrointestinal disorders and is supported by their anatomical locations along stomach and large intestine meridians.

**Standardizing Models and Outcomes Is a Major Future Need**

Despite the volume of research, the authors, led by Lin J and colleagues, point to significant inconsistencies that hinder progress. They note “deficiencies in the standardization of effect evaluation indexes and modeling methods.” For example, while visceral sensitivity is the most common outcome measure, the specific tests and protocols used vary across studies. Similarly, while certain IBS-D animal models are popular, there is no consensus on a gold-standard method.

The team concludes that future studies must optimize evaluation systems and standardize modeling approaches. They also advocate for combining multidisciplinary techniques—such as advanced microbiomics and metabolomics—to more deeply explore the mechanisms. This call for methodological rigor and integrative science is essential for building a more robust, translatable evidence base. It echoes a broader need in gut-brain axis research for precise tools, as seen in the move toward multi-omics for SIBO and gut health diagnosis.

**Practical Implications for Patients and Practitioners**

For individuals with IBS, this analysis suggests that acupuncture, particularly electroacupuncture at specific points, has a growing body of preclinical evidence supporting its effect on multiple drivers of the condition. The strong focus on visceral hypersensitivity is particularly relevant, as this heightened gut sensitivity is a core feature of IBS pain and discomfort. The documented impact on depressive symptoms and behavior also highlights acupuncture’s potential role within a gut-brain axis framework, similar to approaches discussed in articles on IBD, depression and anxiety.

For integrative practitioners, the review confirms a core set of acupoints (ST25, ST36, ST37) for IBS, especially the diarrhea-predominant subtype. It also supports the use of electroacupuncture as a primary modality in clinical protocols. Understanding that the research points to anti-inflammatory, gut barrier-protecting, and microbiome-modulating effects can help inform conversations with patients about how the treatment may work.

The finding that over half the research is on IBS-D also indicates a relative gap in robust experimental models for constipation-predominant IBS (IBS-C), mirroring clinical challenges in the IBS-C treatment gap.

**Reference**

Lin J, Weng Z, Zhang F, et al. [Experimental studies on acupuncture-moxibustion for irritable bowel syndrome in the past five years: a literature analysis]. Zhongguo Zhen Jiu. 2026;46(9):1554-1561. doi:[10.13703/j.0255-2930.20250826-k0001](https://doi.org/10.13703/j.0255-2930.20250826-k0001). PMID: 42744646.